TrialBMJ open2021

Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.

Anders Kjellberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.